References in periodicals archive ?
Four to remember: Cincinnati freshman guard DerMarr Johnson, a Parade All-American last year; Duke freshman guard Jason Williams, who's as talented as Bobby Hurley and William Avery; Connecticut sophomore forward Ajou Deng, who redshirted last year, and Illinois transfer forward Marcus Griffin.
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety.
San Antonio Leon Smith Forward ML King High (Chicago)
Forward Management, LLC, based in San Francisco, is the investment advisor to the Forward Funds, a family of fourteen mutual funds.
Padgett has good range from the perimeter and can play power forward.
InForm's tangible benefits and the product's broad installed base have already contributed to several recent new business wins; ICON and Phase Forward jointly secured four separate clinical trial wins in the last quarter of 2006.
With the 22nd pick, the Clippers selected Brian Skinner, a 6-foot-9 forward from Baylor, who averaged 18.
Through program notes and talks during the concert about the background of the pieces to be performed, Forward said he wants to present the social and historical context from which the music was derived.
Dana-Farber/Harvard Cancer Center is one of the most respected research institutions in the world, and we're honored to serve as a strategic partner," said Bob Weiler, president and chief executive of Phase Forward.
Phase Forward is pleased to play a role in a study with such important public health implications," said Bob Weiler, president and CEO, Phase Forward.
CTSD offers our customers an additional level of insight," said Bob Weiler, president and chief executive officer, Phase Forward.
I'm privileged to have been selected by the Mass Technology Leadership Council, and grateful to the Council for honoring Phase Forward in this way," said Weiler.
Data generated by GleneaglesCRC can now be easily integrated with data from the top pharmaceutical companies using the same Phase Forward software.
We look forward to continued success with our customers and partners in the year ahead as we work to ensure that organizations and researchers are armed with the technology they need to help deliver effective, safer drugs and therapies to market more quickly.